Corey Casper, MD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Recordati Rare Disease
    Topic:
    Castleman Disease
    Date added:
    03/25/2024
    Date updated:
    03/25/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Viracta Therapeutics
    Topic:
    EBV Positive Lymphoma
    Date added:
    03/25/2024
    Date updated:
    03/25/2024
    Relationship end date:
    01/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ImmunityBio
    Topic:
    RNA Vaccines
    Date added:
    03/25/2024
    Date updated:
    03/25/2024
    Relationship end date:
    03/02/2027
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen Pharmaceutical
    Topic:
    Vaccines
    Date added:
    03/25/2024
    Date updated:
    03/25/2024
    Relationship end date:
    12/31/2024
Return to 2024 Binaytara Global Oncology Summit